ENDRA Life Sciences Stock Forecast
NASDAQ: NDRAHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NDRA analyst consensus
Consensus
none
Avg. price target
$25.00+321.59%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $25.00, with a high estimate of $25.00 and a low estimate of $25.00. The average target implies upside of 321.6% from the current price of $5.93. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for NDRA.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $25.00 | +321.59% |
| Average target | $25.00 | +321.59% |
| High target | $25.00 | +321.59% |